Advertisement
U.S. markets closed

Kingworld Medicines Group Limited (1110.HK)

HKSE - HKSE Delayed Price. Currency in HKD
0.590-0.010 (-1.67%)
As of 04:08PM HKT. Market open.

Kingworld Medicines Group Limited

Majialong Chuangxin Building
8th - 9th Floors, Block A 198 Daxin Road Nanshan District
Shenzhen 518016
China
86 755 8229 2888
https://www.kingworld.com.cn

Sector(s)Healthcare
IndustryPharmaceutical Retailers
Full Time Employees1,019

Key Executives

NameTitlePayExercisedYear Born
Mr. Li Sheng ZhaoCo-Founder, Chairman & CEO1.53MN/A1958
Ms. Lok San ChanCo-Founder & Executive Director1.37MN/A1963
Mr. Xuhua ZhouExecutive Director553.34kN/A1966
Mr. Hon Wan Chan CACFO, Financial Controller & Company SecretaryN/AN/A1961
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products. It offers products for relieving cough, eliminating phlegm, soothing asthma, curing influenza, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. The company also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices. It serves in the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.

Corporate Governance

Kingworld Medicines Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.